The FDA will now require warnings on the labels of general anesthetic and sedation drugs. The agency urges healthcare providers to “balance the benefits of appropriate anesthesia in young children and pregnant women against potential risks,” especially if the exposure will be longer than 3 hours or if multiple procedures are needed.
According to the FDA, human studies have shown a single, short exposure to such drugs for infants and toddlers likely won’t have adverse effects, but further research is needed.
More articles on patient safety:
7 hospitals notifying patients of heater-cooler infection risks
Redefining patient safety in 2017 — 6 thoughts from IHI CEO Derek Feeley
Tenet hospital’s Medicare funding no longer in jeopardy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
